Reduced parietooccipital white matter glutamine measured by proton magnetic resonance spectroscopy in treated Graves' disease patients

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 8, 2008, Pages 3192-3198

  Danielsen, E R ^a,b   Elberling, T V ^a   Rasmussen, A K ^a   Dock, J ^a   Hording M ^a   Perrild, H ^a   Waldemar, G ^a   Feldt Rasmussen, U ^a   Thomsen, C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; PROPYLTHIOURACIL; THIAMAZOLE; THIONAMIDE;

ADULT; ARTICLE; ATTENTION; BIOCHEMISTRY; BRAIN; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG BRAIN LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOCRINOLOGY; FEMALE; FOLLOW UP; GRAVES DISEASE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; OCCIPITAL LOBE; OUTPATIENT DEPARTMENT; PARIETAL LOBE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; PRURITUS; RADIOLOGY DEPARTMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; THYROID FUNCTION; THYROTOXICOSIS; VOLUNTEER; WHITE MATTER;

EID: 49249105139     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2161     Document Type: Article

References (23)

1. McLachlan SM, Papoport B 2000 Genetic factors in thyroid disease. In: Braverman L, Utiger R, eds. Werner, Ingbar's the thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams, Wilkins; 474-487
2. Zeitlhofer J, Saletu B, Stary J, Ahmadi R 1984 Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy. Neuropsychobiology 11:89-93
3. Paschke R, Harsch I, Schlote B, Vardarli I, Schaaf L, Kaumeier S, Teuber J, Usadel KH 1990 Sequential psychological testing during the course of autoimmune hyperthyroidism. Klin Wochenschr 68:942-950
4. Vogel A, Elberling TV, Hording M, Dock J, Rasmussen AK, Feldt-Rasmussen U, Perrild H, Waldemar G 2007 Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocreinology 32:36-43
5. Bhatara VS, Tripathi RP, Sankar R, Gupta A, Khushu S 1998 Frontal lobe proton magnetic-resonance spectroscopy in Graves' disease: a pilot study. Psychoneuroendocrinology 23:605-612
6. Elberling TV, Danielsen ER, Rasmussen AK, Feldt-Rasmussen U, Waldemar G, Thomsen C 2003 Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves' disease. Neurology 60:142-145
7. Perrild H, Hansen JM, Arnung K, Olsen PZ, Danielsen U 1986 Intellectual impairment after hyperthyrodism. Acta Endocrinol (Copenh) 112:185-191
8. Bommer M, Eversmann T, Peckardt R, Leonhardt A, Naber D 1990 Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism. Klin Wochenschr 68:552-558
9. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H, Waldemar G 2004 Impaired health-related quality of lift in Graves' disease. A prospective study. Eur. J. Endocrinol 151:549-555
10. Danielsen ER, Ross B 1999 Magnetic resonance spectroscopy diagnosis of neurological diseases. 1st ed. New York: Marcel Dekker
11. Hamilton M 1967 Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296
12. Bech P 1996 The Bech, Hamilton, and Zung scales for mood disorders. Screening and listening. A twenty years' update with reference to DSM-IV and ICD-10. Berlin: Springer; 43-53
13. Hamilton M 1959 The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
14. Hamilton M 1969 Diagnosis and rating of anxiety. Br J Psychiatry (special publication) 3:76-79
15. Bech P, Bolwig TG, Kramp P, Rafaelsen OJ 1979 The Bech-Rafaelsen mania scale and the Hamilton depression scale. Acta Psychiatr Scand 59:420-430
16. Provencher S 1993 Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
17. Schirmer T, Auer D 2000 On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 13:28-36
18. Videen JS, Michaelis T, Pinto P, Ross BD 1995 1995 Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest. 95:788-793
19. Kreis R, Farrow N, Ross BD 1990 Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 336:635-636
20. i co-transport activity in intestinal brush border membrane: role of membrane lipid composition and fluidity. Mol Cell Biochem 278:195-202
21. i co-transport activity in rat renal brush border membranes: role of membrane lipid composition and fluidity. Mol Cell Biochem 268:75-82
22. Kumar V, Prasad R 2002 Molecular basis of renal handling of calcium in response to thyroid hormone status of rat. Biochim Biophys Acta 1586: 331-343
23. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F 2000 Reduced glutamate in the anterior cingulated cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 47:305-313